Работы, на которые ссылается эта работа
Работ: 125
Работа: Recent progress and the emerging role of lncRNAs in cancer drug resistance; focusing on signaling pathways
A view on drug resistance in cancer
Neil Vasan, José Baselga, David M. Hyman
Обзорная статья2019Цитирований: 7ABIResearch progress on the circRNA/lncRNA-miRNA-mRNA axis in gastric cancer
Xuemei Zeng, Juan Xiao, Xue Bai +5
Обзорная статья2022Цитирований: 6ABILong non-coding RNAs: definitions, functions, challenges and recommendations
John S. Mattick, Paulo Amaral, Piero Carninci +26
Обзорная статья2023Цитирований: 6ABIGene regulation by long non-coding RNAs and its biological functions
Luisa Statello, Chunjie Guo, Ling‐Ling Chen +1
Обзорная статья2020Цитирований: 5ABIHypoxic microenvironment in cancer: molecular mechanisms and therapeutic interventions
Zhou Chen, Fangfang Han, Yan Du +2
Обзорная статья2023Цитирований: 5ABIRole of hypoxia in cancer therapy by regulating the tumor microenvironment
Xinming Jing, Fengming Yang, Chuchu Shao +4
Обзорная статья2019Цитирований: 4ABIApplications of machine learning in drug discovery and development
Jessica Vamathevan, Dominic A. Clark, Paul Czodrowski +8
Обзорная статья2019Цитирований: 4ABIThe Role of Exosomes and Their Applications in Cancer
Yuju Zhou, Ying Zhang, Huan Gong +2
Обзорная статья2021Цитирований: 4ABIMicroRNAs (miRNAs) and Long Non-Coding RNAs (lncRNAs) as New Tools for Cancer Therapy: First Steps from Bench to Bedside
Margherita Ratti, Andrea Lampis, Michele Ghidini +4
Обзорная статья2020Цитирований: 4ABIDrug resistance and combating drug resistance in cancer
Xuan Wang, Haiyun Zhang, Xiaozhuo Chen
Статья2019Цитирований: 3ABIRole of noncoding RNAs and untranslated regions in cancer: A review
Yiping Zhang, Mei-wen Yang, Shu‐Long Yang +1
Обзорная статья2022Цитирований: 3ABIAntibody drug conjugate: the “biological missile” for targeted cancer therapy
Zhiwen Fu, Shijun Li, Sifei Han +2
Обзорная статья2022Цитирований: 3ABITumor cell plasticity in targeted therapy-induced resistance: mechanisms and new strategies
Zhenduo Shi, Kun Pang, Zhuo‐Xun Wu +6
Обзорная статья2023Цитирований: 3ABILncRNA HULC triggers autophagy via stabilizing Sirt1 and attenuates the chemosensitivity of HCC cells
Haojun Xiong, Zhenhong Ni, Jianzhong He +12
Статья2017Цитирований: 3ABIMechanisms and Functions of Long Non-Coding RNAs at Multiple Regulatory Levels
Xiaopei Zhang, Wei Wang, Weidong Zhu +4
Обзорная статья2019Цитирований: 3ABIRole of noncoding RNA in drug resistance of prostate cancer
Lifeng Ding, Ruyue Wang, Danyang Shen +7
Обзорная статья2021Цитирований: 2ABIExosomes in cancer development, metastasis, and drug resistance: a comprehensive review
Asfar S. Azmi, Bin Bao, Fazlul H. Sarkar
Обзорная статья2013Цитирований: 2ABIMultidrug Resistance in Cancer: Understanding Molecular Mechanisms, Immunoprevention and Therapeutic Approaches
Talha Bin Emran, Asif Shahriar, Aar Rafi Mahmud +13
Обзорная статья2022Цитирований: 2ABIThe Different Mechanisms of Cancer Drug Resistance: A Brief Review
Behzad Mansoori, Ali Mohammadi, Sadaf Davudian +2
Обзорная статья2017Цитирований: 2ABIRole of Epithelial to Mesenchymal Transition in Colorectal Cancer
Jian Lu, Marko Kornmann, Benno Traub
Обзорная статья2023Цитирований: 2ABILncRNA UCA1 in anti-cancer drug resistance
Haohao Wang, Zhonghai Guan, Kuifeng He +3
Обзорная статья2017Цитирований: 2ABINoncoding RNAs in gastric cancer: implications for drug resistance
Ling Wei, Jujie Sun, Nasha Zhang +7
Обзорная статья2020Цитирований: 2ABIEpigenetic Determinants of Cancer
Stephen B. Baylin, Peter A. Jones
Обзорная статья2016Цитирований: 2ABI